Skip to main content
ENSC
NASDAQ Life Sciences

Breakthrough Opioid Study Advances: Ensysce Biosciences Gets IRB Nod for Final Phase of PF614-MPAR-102

Tom Rudovsky · Reported by Access Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.535
Mkt Cap
$4.965M
52W Low
$0.314
52W High
$4.85
52W Position info
70% above low
Off High info
89% below high
Rel. Volume
Market data snapshot near publication time

ENSC sits 70% above its 52-week low of $0.314.

Summary

Ensysce Biosciences has secured Investigational Review Board (IRB) approval to initiate Part 3, the final stage, of its PF614-MPAR-102 clinical study. This is a significant step for the company's lead opioid candidate, PF614-MPAR, which incorporates Multi-Pill Abuse Resistance (MPAR®) technology and has received Breakthrough Therapy designation from the U.S. FDA. The approval allows the company to proceed with further characterizing the drug's overdose-protection capabilities, advancing a novel opioid designed to minimize abuse and overdose risk. This positive operational milestone provides a key clinical development for the micro-cap pharmaceutical company, following recent financing activities and a significant S-3 filing for potential share dilution.

At the time of this announcement, ENSC was trading at $0.54 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5M. The 52-week trading range was $0.31 to $4.85. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Access Newswire.


Price Chart

Share this article

Copied!

ENSC - Latest Insights

ENSC
Nov 12, 2026, 11:18 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.380
Real-time Price: $0.3817 info
Change: +$0.0017 (+0.45%) info
Market Cap: $7.468M info
ENSC
Nov 12, 2026, 4:30 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.3871
Real-time Price: $0.3817 info
Change: -$0.0054 (-1%) info
Market Cap: $7.468M info
ENSC
Nov 12, 2026, 4:17 PM EST
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.3871
Real-time Price: $0.3817 info
Change: -$0.0054 (-1%) info
Market Cap: $7.468M info
ENSC
Nov 12, 2026, 4:15 PM EST
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $0.3871
Real-time Price: $0.3817 info
Change: -$0.0054 (-1%) info
Market Cap: $7.468M info
ENSC
Nov 04, 2026, 12:46 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.3719
Real-time Price: $0.3817 info
Change: +$0.0098 (+3%) info
Market Cap: $7.468M info